Patient On A Chip

Scientists at Cedars-Sinai and Boston-based digital health startup Emulate are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant—a new approach to advance precision medicine.Researchers know that people respond differently to foods, drugs, and chemicals. For example, a medication may be effective in one individual, while it makes another even more ill. Until now, we’ve had no way to test
Read More